Neoadjuvant chemotherapy is superior to adjuvant treatment in resectable pancreatic adenocarcinoma

被引：0
|
作者：
Artinyan, A. [1 ]
Anaya, D. [1 ]
Mailey, B. [3 ]
Ellenhorn, J. D. [2 ]
Kim, J. [2 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
[3] UC Irvine Sch Med, Irvine, CA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S80 / S81
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant and Adjuvant Therapy in Resectable Pancreatic Adenocarcinoma
    Johnson, Ryan
    McClelland, Paul H.
    Ahmad, Syed A.
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 2024, 104 (05) : 987 - 1005
  • [2] Is Neoadjuvant Chemoradiotherapy Superior to Neoadjuvant Chemotherapy in Resectable Esophageal Adenocarcinoma?
    Prescott, A. T.
    Koshenkov, V. P.
    Koru-Sengul, T.
    Freiser, M. E.
    Rosati, C.
    Sparling, J. L.
    Allan, B. J.
    Franceschi, D.
    Livingstone, A.
    Avisar, E.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S108 - S108
  • [3] Neoadjuvant treatment for resectable pancreatic adenocarcinoma
    Wong, John
    Solomon, Naveenraj L.
    Hsueh, Chung-Tsen
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2016, 7 (01): : 1 - 8
  • [4] Neoadjuvant versus Adjuvant Chemotherapy for Resectable Pancreatic Adenocarcinoma: A National Cancer Database Analysis
    Hashmi, Ammar
    Kozick, Zachary
    Fluck, Marcus
    Hunsinger, Marie A.
    Wild, Jeffrey
    Arora, Tania K.
    Shabahang, Mohsen M.
    Blansfield, Joseph A.
    [J]. AMERICAN SURGEON, 2018, 84 (09) : 1439 - 1445
  • [5] Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
    Ei, Shigenori
    Takahashi, Shinichiro
    Ogasawara, Toshihito
    Mashiko, Taro
    Masuoka, Yoshihito
    Nakagohri, Toshio
    [J]. GUT AND LIVER, 2023, 17 (05) : 698 - 710
  • [6] Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
    Iyengar, Siddharth
    Nevala-Plagemann, Christopher
    Garrido-Laguna, Ignacio
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [7] A Qualitative Review of Neoadjuvant Chemotherapy in Resectable Pancreatic Adenocarcinoma
    Blair, Alex B.
    Sorber, Rebecca
    Rozich, Noah S.
    Burkhart, Richard A.
    [J]. PANCREAS, 2019, 48 (08) : 973 - 984
  • [8] Neoadjuvant chemotherapy improves outcomes in resectable pancreatic adenocarcinoma
    Christopher, Wade
    Nassoiy, Sean
    Marcus, Rebecca
    Keller, Jennifer
    Chang, Shu-Ching
    Fischer, Trevan
    Bilchik, Anton
    Goldfarb, Melanie
    [J]. SURGERY IN PRACTICE AND SCIENCE, 2022, 11
  • [9] The Fate of Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy
    Irfan, Ahmer
    Rose, J. Bart
    Wang, Thomas N.
    Vickers, Selwyn M.
    Dudeja, Vikas
    Gbolahan, Olumide
    Reddy, Sushanth
    [J]. PANCREAS, 2022, 51 (01) : 100 - 105
  • [10] Adjuvant and neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma
    Leonhardt Carl S.
    Traub Benno
    Hackert Thilo
    Klaiber Ulla
    Strobel Oliver
    Büchler Markus W.
    Neoptolemos John P.
    Department of General
    Department of Surgery
    [J]. 胰腺病学杂志(英文), 2020, 03 (01) : 1 - 11
12345